Literature DB >> 30327218

Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease.

Raymond S Schwartz1, Glenda M Halliday2, Derrick Soh3, Dennis J Cordato4, Jillian J Kril5.   

Abstract

BACKGROUND: Subcortical small vessel disease and vascular risk factors are associated with motor and cognitive impairment. In this study we examined the relationship between these factors and the severity of motor impairment and dementia in pathologically-confirmed Parkinson's disease (PD).
METHODS: The extent and severity of small vessel disease (SVD) was assessed pathologically in 77 patients with PD. The severity of motor impairment was determined using a cumulative index derived from longitudinal measures of Hoehn and Yahr score. The presence of dementia was scored using the Clinical Dementia Rating. The presence or absence of vascular risk factors and stroke were also recorded. Interactions were assessed using stepwise multiple regression analyses.
RESULTS: Significant correlations were demonstrated between perivascular pallor in the globus pallidus interna and the Hoehn and Yahr stage and between increasing Braak PD stage, the number of vascular risk factors and dementia. Among the vascular risk factors, hypertension was the only variable to independently correlate with dementia. SVD pathology did not correlate with dementia in our cohort.
CONCLUSIONS: This study demonstrates an association between SVD and motor impairment, and between vascular risk factors, particularly hypertension, and dementia in PD and highlights the need to manage vascular co-morbidities in PD patients. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dementia severity; Motor dysfunction severity; Parkinson’s disease; Small vessel disease pathology; Vascular risk factors

Mesh:

Year:  2018        PMID: 30327218     DOI: 10.1016/j.jocn.2018.10.029

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Understanding the links between cardiovascular disease and Parkinson's disease.

Authors:  Judy Potashkin; Xuemei Huang; Claudia Becker; Honglei Chen; Thomas Foltynie; Connie Marras
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

2.  Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3.

Authors:  Kelly Z Young; Naw May P Cartee; Magdalena I Ivanova; Michael M Wang
Journal:  Exp Neurol       Date:  2020-02-28       Impact factor: 5.330

3.  Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease.

Authors:  Hsin-Hsi Tsai; Li-Kai Tsai; Yen-Ling Lo; Chin-Hsien Lin
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

4.  The Impact of Type 2 Diabetes in Parkinson's Disease.

Authors:  Dilan Athauda; James Evans; Anna Wernick; Gurvir Virdi; Minee L Choi; Michael Lawton; Nirosen Vijiaratnam; Christine Girges; Yoav Ben-Shlomo; Khalida Ismail; Huw Morris; Donald Grosset; Thomas Foltynie; Sonia Gandhi
Journal:  Mov Disord       Date:  2022-06-14       Impact factor: 9.698

5.  Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.

Authors:  Ruth Brauer; Li Wei; Tiantian Ma; Dilan Athauda; Christine Girges; Nirosen Vijiaratnam; Grace Auld; Cate Whittlesea; Ian Wong; Tom Foltynie
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.